333 related articles for article (PubMed ID: 19147430)
1. [Molecular mechanisms of action of some immunosuppressive drugs].
Liberman AC; Druker J; Refojo D; Arzt E
Medicina (B Aires); 2008; 68(6):455-64. PubMed ID: 19147430
[TBL] [Abstract][Full Text] [Related]
2. Drugs in autoimmune diseases.
Herrmann DB; Bicker U
Klin Wochenschr; 1990; 68 Suppl 21():15-25. PubMed ID: 2198387
[TBL] [Abstract][Full Text] [Related]
3. [Immunosuppressive drugs and renal transplantation].
Stallone G; Infante B; Gesualdo L
G Ital Nefrol; 2005; 22 Suppl 33():S76-9. PubMed ID: 16419011
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide.
Brazelton TR; Morris RE
Curr Opin Immunol; 1996 Oct; 8(5):710-20. PubMed ID: 8902398
[TBL] [Abstract][Full Text] [Related]
5. [Today in molecular mechanisms of immunosuppressive drugs actions: roles of pharmacist].
Hulin A
Ann Pharm Fr; 2008 Mar; 66(2):102-14. PubMed ID: 18570909
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of action of immunosuppressive agents].
Frey BM
Ther Umsch; 1993 Feb; 50(2):71-6. PubMed ID: 8456418
[TBL] [Abstract][Full Text] [Related]
7. Clinical immunotoxicity of antirheumatic drugs.
Bálint G; Gergely P
Inflamm Res; 1996 Dec; 45 Suppl 2():S91-5. PubMed ID: 8988409
[TBL] [Abstract][Full Text] [Related]
8. [Immunosuppressive drugs and autoimmune diseases].
Rossert J; Druet P
Ann Biol Clin (Paris); 1991; 49(6):327-37. PubMed ID: 1759727
[TBL] [Abstract][Full Text] [Related]
9. Long-term complications of conventional immunosuppressive treatment.
Boitard C; Bach JF
Adv Nephrol Necker Hosp; 1989; 18():335-54. PubMed ID: 2493723
[TBL] [Abstract][Full Text] [Related]
10. Advances in immunosuppressive therapy.
Marder W; McCune WJ
Semin Respir Crit Care Med; 2007 Aug; 28(4):398-417. PubMed ID: 17764058
[TBL] [Abstract][Full Text] [Related]
11. Influence of immunosuppressive drugs on dendritic cells.
Abe M; Thomson AW
Transpl Immunol; 2003; 11(3-4):357-65. PubMed ID: 12967788
[TBL] [Abstract][Full Text] [Related]
12. New directions in allergic diseases: mechanism-based anti-inflammatory therapies.
Barnes PJ
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):5-16. PubMed ID: 10887299
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive drugs in clinical medicine.
ten Berge RJ; Schellekens PT
Neth J Med; 1994 Dec; 45(6):329-38. PubMed ID: 7838250
[TBL] [Abstract][Full Text] [Related]
14. Steroids and immunosuppressant drugs in myasthenia gravis.
Sathasivam S
Nat Clin Pract Neurol; 2008 Jun; 4(6):317-27. PubMed ID: 18493241
[TBL] [Abstract][Full Text] [Related]
15. [What is meant with immunosuppression?].
Hammer C
Krankenpfl J; 1985; 23(7-8):11-5. PubMed ID: 3850219
[No Abstract] [Full Text] [Related]
16. [The mode of action of immunosuppressors].
Bach JF
Actual Pharmacol (Paris); 1974; 27():23-44. PubMed ID: 4620128
[No Abstract] [Full Text] [Related]
17. The pharmacokinetics and pharmacodynamics of immunosuppressive agents.
Lake KD; Kilkenny JM
Crit Care Nurs Clin North Am; 1992 Jun; 4(2):205-21. PubMed ID: 1599643
[TBL] [Abstract][Full Text] [Related]
18. Nonsteroid immune modulators and bone disease.
Tamler R; Epstein S
Ann N Y Acad Sci; 2006 Apr; 1068():284-96. PubMed ID: 16831929
[TBL] [Abstract][Full Text] [Related]
19. The use of systemic immune moderators in dermatology: an update.
Kazlow Stern D; Tripp JM; Ho VC; Lebwohl M
Dermatol Clin; 2005 Apr; 23(2):259-300. PubMed ID: 15837155
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic use of glucocorticoids and immunosuppressive agents].
Grbović L; Radenković M
Srp Arh Celok Lek; 2005 Oct; 133 Suppl 1():67-73. PubMed ID: 16405260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
